According to Burning Rock Biotech's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.980821. At the end of 2023 the company had a P/S ratio of 1.26.
Year | P/S ratio | Change |
---|---|---|
2023 | 1.26 | -56.09% |
2022 | 2.86 | -77.44% |
2021 | 12.7 | -66.96% |
2020 | 38.4 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
LabCorp LH | 1.31 | 33.39% | ๐บ๐ธ USA |
OpGen
OPGN | 1.90 | 93.50% | ๐บ๐ธ USA |
NeoGenomics
NEO | 3.18 | 223.96% | ๐บ๐ธ USA |